Depressed patients who've used cocaine in the past might be more likely to develop bipolar disorder. A review of de Azevedo Cardoso T, Jansen K, Mondin TC, et al. Lifetime cocaine use is a potential predictor for conversion from major depressive disorder to bipolar disorder: a prospective study. Psychiatry Clin...

Introducing 60 Second Psych, a series of super short episodes presenting bottom line assessments of useful studies in psychiatry.Before you tell your patient how good they're going to feel once they get that sleep apnea treated, check out this review of Wang ML, Wang C, Tuo M, et al. Cognitive...

Introducing 60 Second Psych, a series of super short episodes presenting bottom line assessments of useful studies in psychiatry.An international task force issues a warning about the risk of cardiovascular disease in bipolar disorder. A review of: Goldstein BI, Baune BT, Bond DJ, et al. Call to Action Regarding the...

How to connect to clients in the digital world, featuring an interview with Dr. Peter Yellowlees, author of the APA textbook on telepsychiatry. Plus the word of the day: Synaesthesia.Date Published: 5/4/20Duration: 15 minutes, 36 secondsArticle Referenced: "Telepsychiatry: From Crisis to Opportunity," The Carlat Psychiatry Report, May 2020 (Forthcoming)Got feedback? Take the podcast survey.

There's a new crop of psych meds that work through serotonin receptors, but not in the way you'd expect. They range from antipsychotics like lumateperone (Caplyta) to novel therapies for depression and anxiety like psilocybin and MDMA, as well as a few familiar meds like mirtazapine, trazodone, and quetiapine. Learn how the...

Lithium takes on the coronavirus. Benzos impair facial recognition. Antipsychotic doses find their maximum, the profile of a lithium responder, and topiramate for compulsive shopping.Published On: 4/21/20Duration: 13 minutes, 51 secondsStudies Referenced: Garcez H, Fernandes C, Barbosa F, et al. Effects of benzodiazepines administration on identification of facial expressions of...

We speak with David Osser, whose psychopharmacology algorithm project challenges many conventions about psychiatric medications. When antidepressants cause more depression. Psychotic disorders that don't respond to antipsychotics. When to trust the evidence, and what to do with clinical experience.Published on: 4/13/20Duration: 18 minutes, 56 secondsRelated Articles: "The Psychopharmacology Algorithm Project," The Carlat...

The COVID19 pandemic has our society locked down and our health care system under extreme pressure. In this episode we’ll talk about telepsychiatry, dealing with insurance companies, refilling prescriptions, strategies for living under lockdown, and how to support families and each other during a global pandemic. Published On: 4/9/20 Duration: 18 minutes,...

We're supposed to move to clozapine after two failed antipsychotics in schizophrenia, but how many of us are really doing that?  Not enough. Clozapine may be difficult to use, but it is life changing for many patients. Here we bring you 7 tips, from serum plasma levels to little-known side...

Some antidepressants get better as the dose goes higher, while others just fizzle. For older patients, the side effects stack up as the benefits plateau. We review 3 new meta-analyses on antidepressant dosing, and bring you 4 updates on how the coronavirus is changing practice regulation.Date Published: 3/30/2020Duration: 27 minutes,...